Navigation Links
GHS Cancer Institute and USC School of Medicine Partner on Nation’s First Human Performance Lab to Tackle Cancer Fatigue

Greenville, S.C. (PRWEB) November 23, 2013

The Greenville Health System’s Human Performance Laboratory – expected to open in January 2014 – is the first HPL in the nation to be fully embedded into a cancer research and treatment program.

The HPL, which already is working with a limited number of patients on a pilot basis, is a collaborative effort between GHS and the University Of South Carolina School Of Medicine Greenville. While its initial focus is on cancer survivor patients in the GHS Cancer Institute, the lab will ultimately serve all GHS clinical populations.

Human performance labs traditionally have been the province of elite athletes who use the state-of-the-art analysis to improve performance. This the first time that a HPL will be used by a cancer institute to measure the changes in post-treatment cancer survivors -- from whole body function all the way down the cellular level -- in an effort to improve patient health and outcomes. The 1,000-square-foot lab, based at the GHS Cancer Institute, will measure cardiorespiratory fitness, muscular strength, body composition and metabolic fitness down to the mitochondrial level.

“By determining how exercise affects survivor’s health and outcomes, we can develop new cancer management techniques that will help patients overcome the crippling fatigue that too often accompanies cancer treatment,” said the institute’s medical director, Larry Gluck, MD.

“If achieved, this patient-recovery milestone would be on par with how chemotherapy-induced nausea was significantly reduced by harnessing better-targeted medications, said Gluck. “It’s not enough to survive. You have to feel like you’re actually living a life,” he said.

As many as 200-300 patients could take part in the Human Performance Lab in its first year.

Gluck is a leader in the national cancer-rehab movement. He started the GHS “Moving On” oncology rehabilitation program in 1992 with a dozen breast cancer survivors. It was the first oncology-rehabilitation program in the nation. What physicians found, while anecdotal, was phenomenal.

“Almost without exception that two-week mark was a psychological and physiological turning point,” said Gluck. “My patients have often told me that ‘You may have cured me of my cancer, but Moving On gave me my life back.’”

The current Moving On program is now housed within GHS’ Center for Integrative Oncology and Survivorship. The center, which opened last summer, also offers psychosocial, spiritual and integrative therapies such as cancer-centric nutrition, yoga and acupuncture. GHS was the first hospital in the nation to partner with Cancer Support Community to offer social and emotional support for cancer patients and their caregivers.

“Thanks to advances in more complete cancer care, we now use oncology rehabilitation for cancer survivors the same way we use cardiac rehabilitation for heart patients,” said the center’s medical director Mark O’Rourke, MD. “Our ultimate goal is to have oncology rehabilitation be insurance reimbursable, just like the other programs.”

Just last year, the American Cancer Society announced that the scientific evidence shows that regular physical activity not only helps prevent cancer, but that physical activity after cancer diagnosis may reduce risk of recurrence and improve overall mortality among multiple cancer survivor groups.

Exercise may decrease the risk of colon cancer by 60 percent, and recurrence of breast cancer may decrease as much as 50 percent, according to current research.

“Exercise is the very thing that cancer survivors need to do to decrease their chances of recurrence or second cancers independent of the first,” said Jennifer Trilk, PhD, lab director and clinical assistant professor at the USC School of Medicine Greenville.

“We can now say with confidence that exercise is an important therapy in cancer survivors in addition to chemotherapy or hormonal treatments,” said Trilk. “In addition, preliminary research demonstrates that exercise may protect against, as well as reverse, some of the muscle wasting that occurs as a result of cancer therapy.”

Trilk and her medical students will be measuring the effects of exercise on patients who have undergone cancer therapy. Using the lab, the group will be able to objectively measure changes after the 12-week nurse-supervised Moving On exercise program.

“Dr. Gluck, Dr. O’Rourke and I believe that cancer survivors who exercise during and after cancer treatment have better physiological health, functional health, cognitive health and quality of life than cancer survivors who don’t exercise,” said Trilk. “I’m thrilled to be able to perform patient-meaningful research in an academic health center – and to work with medical students firsthand to demonstrate the importance of exercise for patients, as well as for physicians’ own health.”

Trilk and colleagues will measure patients’ cardiorespiratory fitness, which is associated with decreased cancer risk and greater longevity, and metabolic fitness, which is associated with muscle quality and function. Using dual x-ray absorptiometry, researchers also will measure cancer survivors’ body composition, which gives a detailed assessment of the body’s muscle and fat content and location.

“Most people are aware that having high body fat is unhealthy, but not everyone knows that fat deposited around the organs in the midsection is highly associated with cardiovascular disease and cancer,” Gluck said.

Gluck has long suspected that chemotherapy and radiation therapy might damage mitochondrial function and help explain cancer patients’ feeling of fatigue. And while most chemotherapy does not cross the blood brain barrier, it does produce elements that do, and researching this may lead investigators to a better understanding of the phenomena.

Mitochondria, called the powerhouse of the cell, are found in every cell in the human body and convert the energy of food into power for the muscle and brain cells. If the mitochondria are damaged, muscle and brain cells lose the ability to function properly, and patients experience extreme muscle and mental fatigue, cognitive impairment and memory loss. Post-chemotherapy cognitive impairment (PCCI), also known as chemotherapy-induced cognitive dysfunction or “chemo brain,” may likewise improve with exercise, said the researchers.

Trilk will use near-infrared spectroscopy (NIRS), a non-invasive instrument that measures muscle health and function at the cellular level, to study mitochondria. This is the first time this technology will be used to investigate mitochondrial function in cancer patients.

“We know, by our research to date, that cancer survivors need to avoid being sedentary and instead engage in physical activity,” said Regina Franco, nurse practitioner and manager of the Center for Integrative Oncology and Survivorship – and herself a breast cancer survivor.

“We also know that cancer survivors after treatment commonly have major functional limitations. Some will participate in physical therapy or occupational therapy, but that’s not the whole picture,” said Franco.

“We want to crack the mystery of this entire process, and the Human Performance Lab will enable us to take the analysis much higher level than ever before,” said Franco. “By combining disciplines and expertise, our team will not only help our own patients, but we hope pave the way toward development of a new worldwide standard that will have a significant impact on survivorship.”


Contacts: GHS, Sandy Dees, 864/303-4115, sdees(at)ghs(dot)org
USC, Jeff Stensland, 803/777-3686, stenslan(at)mailbox(dot)sc(dot)edu

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... ORLANDO, Fla. , Oct. 2, 2017  AllianceRx ... services company formed by Walgreens and pharmacy benefit manager ... of its new brand, which included the unveiling of ... Fla. , as well as at a few ... introduces the new brand to patients, some of whom ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: